Cytokines and growth factors in the regulation of bone remodeling

Journal of Bone and Mineral Research

Volumn 8, Issue 2 S, 1993, Pages S505-S510

  Mundy, Gregory R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ARACHIDONATE 5 LIPOXYGENASE; BONE MORPHOGENETIC PROTEIN; CELL RECEPTOR; COLONY STIMULATING FACTOR 1; CYTOKINE; GROWTH FACTOR; LEUKOTRIENE; OSTEOCALCIN; PROSTAGLANDIN E; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA;

AGING; ALBERS SCHOENBERG DISEASE; ANIMAL CELL; BONE ATROPHY; BONE REMODELING; CALVARIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; FETUS; HUMAN; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; RAT;

AGING; ANIMAL; BONE REMODELING; BONE RESORPTION; CELL DIVISION; CYTOKINES; GROWTH SUBSTANCES; HUMAN; OSTEOCLASTS; OSTEOPETROSIS; OSTEOPOROSIS; PROTO-ONCOGENE PROTEIN PP60(C-SRC); SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027717065     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.5650081315     Document Type: Article

References (44)

1. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflection of dyscrasias
2. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations
3. Effects of interleukin 1 on bone turnover in normal mice
4. Bolus injections of recombinant human interleukin 1 cause transient hypocalcemia in normal mice
5. c‐src expression of osteoclasts to form ruffled borders and resorb bone
6. The role of growth factors in skeltal remodeling
7. 1
8. Purification and partial sequence of human osteoclast‐activating factor: Identity with interleukin 1 beta
9. Macrophage colony‐stimulating factor restores in vivo bone resorption in the OP/OP osteopetrotic mouse
10. Interleukin 6 is produced by bone and modulated by parathyroid hormone
11. 5‐Lipoxygenase metabolites of a stromal cell line (C433) activate osteoclasts and giant cells from human giant cell tumors of bone
12. 17β‐Estradiol inhibits interleukin 6 production by bone marrow‐derived stromal cells in osteoblasts in vitro: A potential mechanism for the anti‐osteotropic effect of estrogens
13. The bone‐resorbing activity of interlukin 6–Reply
14. Actions of recombinant interleukin 1, interleukin 2 and interferon gamma on bone resorption in vitro
15. Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin 1 activity
16. IL‐6 is produced by osteoblasts and induces bone resorption
17. Increased osteoclast development after estrogen loss—Mediation by interleukin 6
18. Prostaglandins: Stimulation of bone resorption in tissue culture
19. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony‐stimulating factor
20. Osteoinductive factor inhibits formation of human osteoclastlike cells
21. Isolation of a murine osteoclast colony‐stimulating factor
22. Osteopetrosis in src‐deficient mice is due to an autonomous defect of osteoclasts
23. Effects of human recombinant CSF‐GM and highly purified CSF‐1 on the formation of multinucleated cells with osteoclast characteristics in long term bone marrow cultures
24. Cytokines, hematopoiesis, osteoclastogenesis, and estrogens
25. Stimulation of bone resorption by lipoxygenase metabolites of arachidonic acid
26. Cytokines of bone
27. Evidence for a functional relationship between proliferation and initiation of osteoblast phenotype development
28. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release
29. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis
30. Interleukin 1 and tumor necrosis factor stimulate the formation of human osteoclast‐like cells in vitro
31. Interleukin 6: An osteotropic factor?
32. Infusions of recombinant human interleukin lα and β cause hypercalcemia in normal mice
33. Natural and recombinant human IL‐1 receptor antagonists block the effects of IL‐1 on bone resorption and prostaglandin production
34. Targeted disruption of the c‐src proto‐oncogene leads to osteopetrosis in mice
35. Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts
36. Hematological characterization of congenital osteopetrosis in op/op mouse
37. Flurbiprofen: A potent inhibitor of alveolar bone resorption in beagles
38. src substrate
39. Blocking of EGF‐dependent cell proliferation by EGF receptor kinase inhibitors
40. A novel osteoclastpoietic peptide: Purification and characterization
41. c‐src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo
42. The murine mutation osteopetrosis is in the coding region of the macrophage colony‐stimulating factor gene
43. Cytokine production by peripheral blood cells in postmenopausal osteoporosis